Robert Goodenow

Robert Goodenow

Nessuna posizione attualmente
76 anni
Health Technology
Consumer Services
Miscellaneous

Profilo

Robert S.
Goodenow
is currently the Chief Executive Officer at Alanis Therapeutics, Inc. He previously worked as a Principal at Baxter International, Inc., Head-Oncology Business Development at Aventis, Inc., Secretary & Chief Business Officer at Syndax Pharmaceuticals, Inc., and Chief Business Officer at HUYA Bioscience International LLC.
From 2002 to 2007, he served as the Vice President-Corporate Development at Inovio Pharmaceuticals, Inc. Dr. Goodenow holds a doctorate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.

Posizioni attive di Robert Goodenow

SocietàPosizioneInizio

Precedenti posizioni note di Robert Goodenow

SocietàPosizioneFine
INOVIO PHARMACEUTICALS, INC. Corporate Officer/Principal 16/03/2007
Presidente -
BAXTER INTERNATIONAL INC. Corporate Officer/Principal -
Corporate Officer/Principal -
SYNDAX PHARMACEUTICALS, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Robert Goodenow

Formazione di Robert Goodenow

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

10

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Miscellaneous

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Mercati
  2. Insiders
  3. Robert Goodenow